Literature DB >> 23457003

Upholding the principles of autonomy, beneficence, and justice in phase I clinical trials.

Taofeek K Owonikoko1.   

Abstract

Mesh：

Year:  2013        PMID： 23457003      PMCID： PMC3607517          DOI： 10.1634/theoncologist.2013-0014

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  9 in total

1.  A summary of important documents in the field of research ethics.

Authors:  Bernard A Fischer
Journal:  Schizophr Bull       Date:  2005-09-28       Impact factor: 9.306

Review 2.  Economics of new oncology drug development.

Authors:  Joseph A DiMasi; Henry G Grabowski
Journal:  J Clin Oncol       Date:  2007-01-10       Impact factor: 44.544

3.  Parallel anticancer drug development and molecular stratification to qualify predictive biomarkers: dealing with obstacles hindering progress.

Authors:  Victor Moreno Garcia; Philippe A Cassier; Johann de Bono
Journal:  Cancer Discov       Date:  2011-08       Impact factor: 39.397

4.  Assessing the impact of protocol design changes on clinical trial performance.

Authors:  Kenneth A Getz; Julia Wenger; Rafael A Campo; Edward S Seguine; Kenneth I Kaitin
Journal:  Am J Ther       Date:  2008 Sep-Oct       Impact factor: 2.688

5.  Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.

Authors:  Rebecca D Pentz; Margaret White; R Donald Harvey; Zachary Luke Farmer; Yuan Liu; Colleen Lewis; Olga Dashevskaya; Taofeek Owonikoko; Fadlo R Khuri
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

Review 6.  New science-based endpoints to accelerate oncology drug development.

Authors:  Gary J Kelloff; Caroline C Sigman
Journal:  Eur J Cancer       Date:  2005-01-22       Impact factor: 9.162

7.  Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.

Authors:  Thomas G Roberts; Bernardo H Goulart; Lee Squitieri; Sarah C Stallings; Elkan F Halpern; Bruce A Chabner; G Scott Gazelle; Stan N Finkelstein; Jeffrey W Clark
Journal:  JAMA       Date:  2004-11-03       Impact factor: 56.272

8.  Risks and benefits of phase 1 oncology trials, 1991 through 2002.

Authors:  Elizabeth Horstmann; Mary S McCabe; Louise Grochow; Seiichiro Yamamoto; Larry Rubinstein; Troy Budd; Dale Shoemaker; Ezekiel J Emanuel; Christine Grady
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

Review 9.  Compliance in early-phase cancer clinical trials research.

Authors:  Razelle Kurzrock; David J Stewart
Journal:  Oncologist       Date:  2013-03-01
  9 in total
  2 in total

Review 1.  Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis.

Authors:  Vaibhav Kumar; Venetia Aranha; Rajni Rajgarhia; Abhishek Royal; Kedar Mehta
Journal:  Hum Vaccin Immunother       Date:  2021-07-15       Impact factor: 4.526

Review 2.  Between a rock and a hard place: Ethics, nurses' safety, and the right to protest during the COVID-19 pandemic.

Authors:  Fhumulani Mavis Mulaudzi; Mutondi Mulaudzi; Rafiat Ajoke Anokwuru; Mashudu Davhana-Maselesele
Journal:  Int Nurs Rev       Date:  2021-09       Impact factor: 2.871
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.